Miller-The ASAM Principles of Addiction Medicine, 7e

45

CHAPTER 3 • The Anatomy of Addiction

29. Comer SD, Turner DM, Carroll ME. Effects of food deprivation on cocaine base smoking in rhesus monkeys. Psychopharmacology (Berl). 1995;119(2):127 ‐ 132. 30. Davis WM, Smith SG. Effect of haloperidol on (+)-amphetamine self administration. J Pharm Pharmacol. 1975;27(7):540 ‐ 542. 31. Wilson MC, Schuster CR. The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey. Psychopharmacologia. 1972;26(2):115 ‐ 126. 32. Yokel RA, Wise RA. Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward. Science. 1975;187(4176):547 ‐ 549. 33. Yokel RA, Wise RA. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychophar macology (Berl). 1976;48(3):311 ‐ 318. 34. De Wit H, Wise RA. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol. 1977;31(4): 195 ‐ 203. 35. Wise RA. Catecholamine theories of reward: A critical review. Brain Res . 1978;152(2):215 ‐ 247. 36. Wise RA, Bozarth MA. Brain substrates for reinforcement and drug self administration. Prog Neuropsychopharmacol. 1981;5(5-6):467 ‐ 474. 37. Roberts DC, Mason ST, Fibiger HC. 6-OHDA lesion to the dorsal noradrenergic bundle alters morphine-induced locomotor activity and catalepsy. Eur J Pharmacol. 1978;52(2):209 ‐ 214. 38. Caine SB, Koob GF. Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food. J Exp Anal Behav. 1994;61(2):213 ‐ 221. 39. Lyness WH, Friedle NM, Moore KE. Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self administration. Pharmacol Biochem Behav. 1979;11(5):553 ‐ 556. 40. DCS R, Koob GF, Klonoff P, Fibiger HC. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav. 1980;12(5):781 ‐ 787. 41. Roberts DCS, Corcoran ME, Fibiger HC. Recovery of cocaine self administration after 6-OHDA lesion of the n.accumbens correlates with residual dopamine levels. In: Usdin E, Kopin IJ, Barchas J, eds. Catecholamines: Basic and Clinical Frontiers . Pergamon; 1979:1774 ‐ 1776. 42. McGregor A, Baker G, Roberts DC. Effect of 6-hydroxydopamine lesions of the amygdala on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement. Brain Res. 1994;646(2):273 ‐ 278. 43. McGregor A, Baker G, Roberts DC. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self administration under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav. 1996;53(1):5 ‐ 9. 44. McGregor A, Roberts DC. Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res. 1993;624(1-2):245 ‐ 252. 45. McGregor A, Roberts DC. Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement. Behav Brain Res. 1995;67(1):75 ‐ 80. 46. Kelly PH, Iversen SD. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol. 1976;40(1):45 ‐ 56. 47. Van Rossum JM. Mode of action of psychomotor stimulant drugs. Int Rev Neurobiol. 1970;12:307 ‐ 383. 48. Pijnenburg AJ, van Rossum JM. Letter: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J Pharm Pharmacol . 1973;25(12):1003-1005. 49. Pijnenburg AJ, Honig WM, Van Rossum JM. Inhibition of d-amphetamine induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacologia. 1975;41(2):87 ‐ 95. 50. Randrup A, Munkvad I. Stereotyped behavior. Pharmacol Ther B. 1975;1(4):757 ‐ 768.

51. Ellinwood EH Jr, Kilbey MM. Amphetamine stereotypy: the influence of environmental factors and prepotent behavioral patterns on its topography and development. Biol Psychiatry. 1975;10(1):3 ‐ 16. 52. Lyon M, Robbins TW The action of central nervous system stimulant drugs: A general theory concerning amphetamine effects. Curr Dev Psychopharmacology. 1975;2:81 ‐ 163. 53. Ahn S, Phillips AG. Modulation by central and basolateral amygdalar nuclei of dopaminergic correlates of feeding to satiety in the rat nucleus accumbens and medial prefrontal cortex. J Neurosci. 2002;22(24): 10958 ‐ 10965. 54. Ahn S, Phillips AG. Independent modulation of basal and feeding- evoked dopamine efflux in the nucleus accumbens and medial prefrontal cortex by the central and basolateral amygdalar nuclei in the rat. Neuroscience. 2003;116(1):295 ‐ 305. 55. Phillips AG, Ahn S, Howland JG. Amygdalar control of the mesocorticolimbic dopamine system: Parallel pathways to motivated behavior. Neurosci Biobehav Rev. 2003;27(6):543 ‐ 554. 56. Ågmo A, Galvan A, Talamantes B. Reward and reinforcement produced by drinking sucrose: 2 processes that may depend on different neurotransmitters. Pharmacol Biochem Behav. 1995;52(2):403 ‐ 414. 57. Ågmo A, Federman I, Navarro V, Padua M, Velazquez G. Reward and reinforcement produced by drinking water: Role of opioids and dopamine receptor subtypes. Pharmacol Biochem Behav. 1993;46(1):183 ‐ 194. 58. Fibiger HC, Nomikos GG, Pfaus JG, Damsma G. Sexual behavior, eating and mesolimbic dopamine. Clin Neuropharmacol. 1992;15(Suppl 1 Pt A):566A ‐ 567A. 59. Mitchell JB, Gratton A. Involvement of mesolimbic dopamine neurons in sexual behaviors: Implications for the neurobiology of motivation. Rev Neurosci. 1994;5(4):317 ‐ 329. 60. Gratton A, Wise RA. Brain stimulation reward in the lateral hypothalamic medial forebrain bundle: Mapping of boundaries and homogeneity. Brain Res. 1983;274(1):25 ‐ 30. 61. Tzschentke TM. The medial prefrontal cortex as a part of the brain reward system. Amino Acids. 2000;19(1):211 ‐ 219. 62. Wise RA. Brain reward circuitry: Insights from unsensed incentives. Neuron. 2002;36(2):229 ‐ 240. 63. White FJ. Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci. 1996;19:405 ‐ 436. 64. Schultz W. Behavioral dopamine signals. Trends Neurosci. 2007;30(5):203 ‐ 210. 65. Phillipson OT. A Golgi study of the ventral tegmental area of Tsai and interfascicular nucleus in the rat. J Comp Neurol. 1979;187(1):99 ‐ 115. 66. Ramon-Moliner E, Nauta WJ. The isodendritic core of the brain stem. J Comp Neurol. 1966;126(3):311 ‐ 335. 67. Geisler S, Zahm DS. Afferents of the ventral tegmental area in the rat-anatomical substratum for integrative functions. J Comp Neurol. 2005;490(3):270 ‐ 294. 68. Martin M, Hurley RA, Taber KH. Is opiate addiction associated with longstanding neurobiological changes? J Neuropsychiatry Clin Neurosci. 2007;19(3):242 ‐ 248. 69. Dykstra LA, Preston KL, Bigelow GE. Discriminative stimulus and subjective effects of opioids with mu and kappa activity: Data from laboratory animals and human subjects. Psychopharmacology. 1997;130(1):14 ‐ 27. 70. Koob GF, Vaccarino FJ, Amalric M, Bloom FE. Neurochemical substrates for opiate reinforcement. NIDA Res Monogr. 1986;71:146 ‐ 164. 71. Mucha RF, Herz A. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berl). 1985;86(3):274 ‐ 280. 72. Tang AH, Collins RJ. Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys. Psychopharmacology (Berl). 1985;85(3):309 ‐ 314. 73. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci. 1987;7(8):2445 ‐ 2464. 74. Wise RA, Hoffman DC. Localization of drug reward mechanisms by intracranial injections. Synapse. 1992;10(3):247 ‐ 263.

Copyright © 2024 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited.